01.002 RWE GS Apr 2022 C 04-05-2022

RWE was essential in understanding and fighting COVID-19, now it must be used to accelerate cancer research

Three reasons why we must continue utilising
  • RWE post-pandemic: RWE studies represent real-world patient populations in real-life settings
  • RWE can elevate patient-centricity (e.g. patient reported outcomes on quality of life)
  • RWE studies identify significant findings more quickly
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at